Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs
- PMID: 15941837
- PMCID: PMC1797984
- DOI: 10.1136/ard.2005.036269
Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs
Abstract
Treatment of pain in rheumatoid arthritis must take into account the gastrointestinal and cardiovascular risk of individual patients. Adequate results are not yet available, and until they are, treatment recommendations must take into account, not only the more favourable gastrointestinal risk profile of selective COX-2 inhibitors, but also the potential atherothrombotic risk of any NSAID or selective COX-2 inhibitor treatment.
Similar articles
-
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.BMJ. 2006 Jun 3;332(7553):1302-8. doi: 10.1136/bmj.332.7553.1302. BMJ. 2006. PMID: 16740558 Free PMC article.
-
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.Circulation. 2007 Apr 24;115(16):2196-207. doi: 10.1161/CIRCULATIONAHA.106.675991. Circulation. 2007. PMID: 17452618 Review. No abstract available.
-
[Pharmacology of non-steroidal anti-inflammatory drugs and ENT pathology].Presse Med. 2001 Dec 22-29;30(39-40 Pt 2):70-9. Presse Med. 2001. PMID: 11819916 French.
-
Why do COX-2 inhibitors increase risk of cardiovascular events?Lancet. 2002 Apr 20;359(9315):1410. doi: 10.1016/S0140-6736(02)08393-9. Lancet. 2002. PMID: 11978344 No abstract available.
-
[Cardiovascular risk of non-steroidal anti-inflammatory drugs].Praxis (Bern 1994). 2012 Oct 3;101(20):1309-14. doi: 10.1024/1661-8157/a001074. Praxis (Bern 1994). 2012. PMID: 23032496 Review. German.
Cited by
-
Colchicine for secondary prevention of cardiovascular disease.Curr Atheroscler Rep. 2014 Mar;16(3):391. doi: 10.1007/s11883-013-0391-z. Curr Atheroscler Rep. 2014. PMID: 24425060 Review.
-
Ischemic heart disease and ankylosing spondylitis-assessing the role of inflammation.Clin Rheumatol. 2018 Apr;37(4):1053-1058. doi: 10.1007/s10067-018-4037-y. Epub 2018 Feb 22. Clin Rheumatol. 2018. PMID: 29473098
-
Issues in the treatment of ankylosing spondylitis with non-steroidal anti-inflammatory drugs.Wien Med Wochenschr. 2008;158(7-8):195-9. doi: 10.1007/s10354-008-0521-3. Wien Med Wochenschr. 2008. PMID: 18500470 Review.
-
Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis.Arthritis Rheum. 2013 Jul;65(7):1675-83. doi: 10.1002/art.37975. Arthritis Rheum. 2013. PMID: 23606026 Free PMC article. No abstract available.
-
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Ther Adv Musculoskelet Dis. 2013 Aug;5(4):166-81. doi: 10.1177/1759720X13491025. Ther Adv Musculoskelet Dis. 2013. PMID: 23904862 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials